Antiphospholipid antibodies (aPL) are both diagnostic markers for, and pathogenic drivers
of, antiphospholipid syndrome (APS). Although the presence of aPL is a necessary pre …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
arterial and venous thrombotic manifestations and/or pregnancy-related complications in …

Objective. To develop and validate a risk score [global APS score (GAPSS)] derived from the
combination of independent risk for thrombosis and pregnancy loss (PL), taking into account …

Antibodies to prothrombin are detected by directly coating prothrombin on irradiated ELISA
plates (aPT) or by using the phosphatidylserine/prothrombin complex as antigen (aPS/PT) …

Current classification criteria for definite Antiphospholipid Syndrome (APS) require the use
of three laboratory assays to detect antiphospholipid antibodies (aCL, anti-β2GPI and LA) in …

Current classification criteria for definite APS recommend the use of one or more of three
positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus …

Objective. The aim of this study was to evaluate the clinical relevance of the global APS
score (GAPSS) in a cohort of primary APS patients. Methods. This study included 62 …

Antiphospholipid syndrome (APS) is an autoimmune condition that is associated with
thrombosis and morbidity in pregnancy. The exact mechanisms by which these associations …

Objective The aim of the study is to perform a systematic review on the recent available
evidence on antiphosphatidylserine/prothrombin (aPS/PT) antibodies and their association …

The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular
thrombosis or miscarriages but includes additional manifestations that cannot be explained …